Vital Specialized Biopharmaceutical Insights and Analytics

for Experts from Experts

BioTrends is the premier provider of analysis and data on the significant issues facing the biopharmaceutical industry.

Learn More

Featured Report
PatientTrends: Rheumatoid Arthritis US

Although there are many treatments available for RA, there is still a high unmet need for new treatments, especially for patients who are refractory to current therapies, such as TNF-alpha inhibitors, the most widely used biologic agents in RA.
Learn More

New Product 
ChartTrends: Chronic Kidney Disease: Non-Dialysis - Renal Anemia 2014 (China)

By comparing what nephrologists report about patient care dynamics to actual treatment records in CKD-ND, gaps in intended care versus actual care are uncovered and patient segments become more clearly defined. This new report covers patient demographics, referral patterns, length of treatment, blood transfusion rates, hospitalization rates and common reasons for referral in the Chinese market.
Learn More

Search Published Reports

TOP TEN REPORTS

See which reports have been searched on the most.

Go

In the Spotlight

New Infographic


Download this new infographic on global biosimilars pathways and clinical development activity. Where are the biosimilars hotspots?
 

Download


DOWNLOAD NOW

Recent Reports [ view all ]

  • Pancreatic Cancer

    Pancreatic cancer (PaC) is one of the most aggressive and highly lethal solid malignancies, with a 5-year survival... Read More

  • Alzheimer's Disease - 2015

    Last Updated 24 March 2015
    The market for Alzheimer’s disease (AD) pharmacotherapies continues to offer... Read More

  • Treatment Algorithms in Retinal Vein Occlusion

    Retinal vein occlusion (RVO), estimated to affect 1.3 million U.S. adults aged 40 or older, is a retinal vascular... Read More

Decision Resources Group brands include: